Soft Tissue Sarcoma Adult Clinical Trials

9 recruiting

Soft Tissue Sarcoma Adult Trials at a Glance

9 actively recruiting trials for soft tissue sarcoma adult are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Oslo, Bergen, and Bordeaux. Lead sponsors running soft tissue sarcoma adult studies include Oslo University Hospital, N.N. Petrov National Medical Research Center of Oncology, and Memorial Sloan Kettering Cancer Center.

Browse soft tissue sarcoma adult trials by phase

Treatments under study

About Soft Tissue Sarcoma Adult Clinical Trials

Looking for clinical trials for Soft Tissue Sarcoma Adult? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Soft Tissue Sarcoma Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Soft Tissue Sarcoma Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Soft Tissue SarcomaSarcomaSarcoma,Soft Tissue+1 more
Memorial Sloan Kettering Cancer Center98 enrolled1 locationNCT04577014
Recruiting

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

SarcomaAngiosarcomaSoft Tissue Sarcoma (STS)+9 more
Royal Marsden NHS Foundation Trust800 enrolled1 locationNCT07432932
Recruiting
Phase 2

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

Soft Tissue Sarcoma (STS)Soft Tissue Sarcoma AdultSynovial Sarcomas+7 more
Oslo University Hospital40 enrolled2 locationsNCT07173972
Recruiting
Phase 2

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Soft Tissue Sarcoma AdultLeiomyosarcomaSynovial Sarcomas+6 more
Oslo University Hospital110 enrolled4 locationsNCT07169344
Recruiting
Phase 2

Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

Soft Tissue Sarcoma Adult
Institut Bergonié119 enrolled10 locationsNCT05182164
Recruiting
Early Phase 1

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma Adult
Pure Biologics S.A.12 enrolled1 locationNCT06700070
Recruiting
Not Applicable

Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Soft Tissue Sarcoma Adult
University Hospital Tuebingen30 enrolled1 locationNCT06385288
Recruiting
Phase 2

Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

AngiosarcomaSoft Tissue Sarcoma AdultUndifferentiated Pleomorphic Sarcoma
Niels Junker80 enrolled4 locationsNCT05961761
Recruiting
Not Applicable

Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy

Soft Tissue Sarcoma Adult
N.N. Petrov National Medical Research Center of Oncology30 enrolled1 locationNCT04330456